~~<i id='7143CD392A'><strike id='7143CD392A'><tt id='7143CD392A'><pre id='7143CD392A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：leisure time 2025-10-01 07:40:03 - browse：8

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Biden report: The neurospychology of memory and aging

entertainment

Wikipedia

entertainment

Wikipedia

focus

AdobeDoctorsarefullofadvice:Eathealthy.Exercise.Don’tmissyourmedications.Don’tgetthatunnecessarytest

WSS

Doctors' information doesn't help them choose wisely when sick

To avoid data mishandling cases, universities eye AI and other tools

KalVista pill reduced swelling 'attacks' caused by genetic disease

Medicare Advantage proposed rates disappoint insurers

To avoid data mishandling cases, universities eye AI and other tools

Doctors' information doesn't help them choose wisely when sick

explore

knowledge

entertainment

Cancer drug shortages should be causing more outrage

Biden report: The neurospychology of memory and aging

How one medical school became remarkably diverse

Industry veterans launch new biotech VC with $310M

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Psychedelics group wrestles with new pharma identity

What we’ve learned from the Aduhelm mess

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Senators start work on Medicare physician payment reform

Wikipedia

What we’ve learned from the Aduhelm mess

Medicare Advantage proposed rates disappoint insurers

Gilead might be held responsible for not developing a drug

Medicare threatens to cut off funding for HCA's Mission hospital

Industry veterans launch new biotech VC with $310M

BioAge raises $170M for combination therapy with Zepbound

Wikipedia

entertainment

Wikipedia

focus